Emmaus Life Sciences Profit Margin 2006-2021 | EMMA
Current and historical gross margin, operating margin and net profit margin for Emmaus Life Sciences (EMMA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Emmaus Life Sciences net profit margin as of June 30, 2021 is -2.6%.
|Emmaus Life Sciences Annual Profit Margins
|Emmaus Life Sciences Quarterly Profit Margins
||Medical - Biomedical and Genetics
Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.